Related Experiment Videos
Prognostic factors in intramedullary astrocytomas
G Innocenzi1, M Salvati, L Cervoni
1Department of Neurosurgery, Mediterranean Neuromed Institute of Neurosciences, IRCCS, Pozzilli (Is), Italy.
Clinical Neurology and Neurosurgery
|February 1, 1997
Summary
Prognostic factors for intramedullary astrocytoma survival were analyzed. Low tumor grade and good patient condition improved outcomes, while specific features in anaplastic types worsened prognosis.
Area of Science:
- Neuro-oncology
- Neurosurgery
- Pathology
Background:
- Intramedullary astrocytomas are primary tumors within the spinal cord.
- Accurate prognostic indicators are crucial for treatment planning and patient counseling.
Purpose of the Study:
- To identify clinical, histological, and therapeutic factors influencing survival in patients with intramedullary astrocytoma.
- To analyze prognostic variables in a long-term retrospective cohort.
Main Methods:
- Retrospective analysis of 65 patients with intramedullary astrocytoma treated surgically between 1953 and 1990.
- Assessment of median and 5-year survival rates.
- Correlation of survival with clinical, histological (tumor grade, specific morphological features), and therapeutic (degree of resection) factors.
Main Results:
- Low histological grade and favorable pre- and post-operative patient conditions were associated with improved prognosis.
- Within Grade II astrocytomas, fibrillary and protoplasmic subtypes showed longer survival, irrespective of resection extent.
- Anaplastic astrocytomas with specific high-malignancy morphological features had a poorer survival outlook.
- The extent of surgical resection did not significantly impact survival within individual histological grades.
Conclusions:
- Histological grade and patient's general condition are key prognostic determinants for intramedullary astrocytoma.
- Specific histological subtypes and features within grades influence survival, independent of surgical approach.
- Further research into molecular markers may refine prognostic accuracy for these spinal cord tumors.